Chodary Khameneh, Sepideh
Razi, Sara
Shamdani, Sara
Uzan, Georges
Naserian, Sina
Funding for this research was provided by:
la Fondation de la Maison de la Chimie (RAK20150LLA)
Article History
Received: 2 August 2021
Accepted: 7 February 2022
First Online: 22 February 2022
Competing interests
: Dr. Sina NASERIAN is the deputy Chief Scientific and Technical Officer at ScreenCell Company. Dr. Sara SHAMDANI is the General Director of the CellMedEx Company. The rest of the authors declare that they have no competing interests.